Pulmonary Circulation (Jan 2021)
Inhaled iloprost as third add-on therapy in idiopathic pulmonary arterial hypertension
Abstract
Triple combination therapy is suggested in current pulmonary arterial hypertension guidelines in case of unsatisfactory treatment with oral double combination therapy. However, there is a lack of evidence concerning some of the drug combinations currently employed. We demonstrate the clinical and hemodynamical benefits of inhaled iloprost as third add-on therapy in idiopathic pulmonary arterial hypertension.